|
|
Article: Sunlight Research(TM), Releases Its Amgen EPO Patents Report.
- Article from:
- PR Newswire
- Article date:
- September 14, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Report to be provided on a Complimentary basis at the Intellectual Property Owners Association Annual Meeting in Chicago, September 13-15, 2009
MINNEAPOLIS and CHICAGO, Sept. 14 /PRNewswire/ -- Sunlight Research(TM) - The Source for Patent Analysis (http://www.sunlightresearch.com/) today announced the release of its report analyzing Amgen, Inc.'s Erythropoietin (EPO) US patent portfolio.
The Report analyzes the patent claims coverage of 38 US patents owned or controlled by Amgen , and explains how those patents do or do not cover the corresponding technology used in their commercial product Epogen. The technology focuses on recombinant erythropoietin, ...